NCT04392258

Brief Summary

Time-limited adaptive responses of thyroid function are common in the critically ill. About 70% of all patients treated on intensive care units develop a so-called non-thyroidal illness syndrome (NTIS) or TACITUS (thyroid allostasis in critical illness, tumours, uraemia and starvation), which is marked by low serum concentrations of the thyroid hormone T3 and other adaptive reactions of thyroid homeostasis. Occasionally, temporarily elevated concentrations of thyrotropin (TSH) and peripheral thyroid hormones are to be observed, especially after cardiopulmonary resuscitation (CPR). However, the available evidence is limited, although abnormal concentrations of thyroid hormones after CPR have occasionally been reported. Aim of the planned study is to investigate the thyrotropic (i.e. thyroid-controlling) partial function of the anterior pituitary lobe immediately after CPR. It is intended to evaluate statistical measures of TSH concentration and peripheral thyroid hormones in de-identified datasets (protocol A). Additionally, a prospective sub-study (protocol B) aims at a more precise description of pituitary and thyroid responses by means of serial investigations in routine serum samples, both immediately after CPR and during the course of ongoing treatment. This includes the evaluation of additional possible predictors, too. Primary endpoint of the study is changed TSH concentration immediately after CPR compared to the TSH value 24 hours later. Secondary endpoint is the relation between thyroid-controlling pituitary function and mortality. A high proportion of patients undergoing CPR will eventually receive iodinated radiocontrast media (e.g. for computed tomography or coronary angiography). This is one of the reasons why early identifying subjects at high risk for possible iodine-induced thyrotoxicosis is important. Increased oxygen consumption of the heart in hyperthyroidism is one of the reasons for high mortality in thyrotoxicosis. Therefore, accurate diagnosis of alterations in the hypothalamus-pituitary-thyroid (HPT) axis is of paramount importance.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 18, 2020

Completed
12 months until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

August 19, 2021

Status Verified

August 1, 2021

Enrollment Period

1.1 years

First QC Date

May 7, 2020

Last Update Submit

August 13, 2021

Conditions

Keywords

thyroidhomeostasisallostasisresuscitationallostatic loadcritical illnessTACITUSNTISCirculatory arrest

Outcome Measures

Primary Outcomes (1)

  • TSH response

    Changes in TSH concentration after CPR compared to the value after 24 hours

    three hours

Secondary Outcomes (1)

  • Prognosis

    Through study completion, an average of 1 year

Study Arms (1)

Status post resuscitation

Patients or dataset that underwent resuscitation

Diagnostic Test: TSH determinationDiagnostic Test: FT4 determinationDiagnostic Test: FT3 determinationDiagnostic Test: SPINA-GTDiagnostic Test: SPINA-GD

Interventions

TSH determinationDIAGNOSTIC_TEST

Determination of serum concentration of thyrotropin (TSH)

Also known as: serum thyrotropin determination
Status post resuscitation
FT4 determinationDIAGNOSTIC_TEST

Determination of serum free thyroxine (FT4) concentration

Also known as: serum free T4 determination
Status post resuscitation
FT3 determinationDIAGNOSTIC_TEST

Determination of serum free triiodothyronine (FT3) concentration

Also known as: serum free T3 determination
Status post resuscitation
SPINA-GTDIAGNOSTIC_TEST

Calculation of thyroid's secretory capacity (SPINA-GT)

Also known as: GT, Thyroid's secretory capacity, LOINC 82368-2, thyroid's incretory capacity
Status post resuscitation
SPINA-GDDIAGNOSTIC_TEST

Calculation of total deiodinase activity (SPINA-GD)

Also known as: GD, Sum activity of peripheral deiodinases, LOINC 82367-4, deiodination capacity
Status post resuscitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

De-identified datasets (protocol A) or patients (protocol B) admitted to an intensive care unit after cardiopulmonary resuscitation (CPR)

You may qualify if:

  • Admission after cardiopulmonary resuscitation
  • Minimum age of 18 years
  • Results of TSH and peripheral thyroid hormone concentrations already available or possibility to reorder these investigations in a post-hoc manner if consent has been obtained (i. e. time interval after venipuncture within the storage period of the central laboratory)

You may not qualify if:

  • Missing data on thyroid homeostasis in the first blood specimen (obtained before 3 hours after admission)
  • Traumatic brain injury
  • Persistent hints for thyroid dysfunction, not explained by non-thyroidal illness syndrome (NTIS) / euthyroid sick syndrome (ESS) / thyroid allostasis in critical illness, tumors, uremia and starvation (TACITUS) in consecutive investigations over several days after resuscitation
  • Functionally relevant thyroid or pituitary disorder, as documented in international classification of diseases (ICD) codes.
  • Exposure to radiocontrast agents less than 3 months ago
  • Therapy with amiodarone (currently or during the previous 3 years)
  • Pregnancy
  • Known thyroid disease
  • Consent not obtained within the routine storage period of the central laboratory

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medizinische Klinik I, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum

Bochum, North Rhine-Westphalia, D-44789, Germany

RECRUITING

Related Publications (7)

  • Dietrich JW, Stachon A, Antic B, Klein HH, Hering S. The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome. BMC Endocr Disord. 2008 Oct 13;8:13. doi: 10.1186/1472-6823-8-13.

    PMID: 18851740BACKGROUND
  • Dietrich JW, Landgrafe G, Fotiadou EH. TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis. J Thyroid Res. 2012;2012:351864. doi: 10.1155/2012/351864. Epub 2012 Dec 30.

    PMID: 23365787BACKGROUND
  • Dietrich JW, Muller P, Schiedat F, Schlomicher M, Strauch J, Chatzitomaris A, Klein HH, Mugge A, Kohrle J, Rijntjes E, Lehmphul I. Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling. Eur Thyroid J. 2015 Jun;4(2):129-37. doi: 10.1159/000381543. Epub 2015 May 23.

    PMID: 26279999BACKGROUND
  • Dietrich JW, Landgrafe-Mende G, Wiora E, Chatzitomaris A, Klein HH, Midgley JE, Hoermann R. Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research. Front Endocrinol (Lausanne). 2016 Jun 9;7:57. doi: 10.3389/fendo.2016.00057. eCollection 2016.

    PMID: 27375554BACKGROUND
  • Chatzitomaris A, Hoermann R, Midgley JE, Hering S, Urban A, Dietrich B, Abood A, Klein HH, Dietrich JW. Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming. Front Endocrinol (Lausanne). 2017 Jul 20;8:163. doi: 10.3389/fendo.2017.00163. eCollection 2017.

    PMID: 28775711BACKGROUND
  • Muller P, Dietrich JW, Lin T, Bejinariu A, Binnebossel S, Bergen F, Schmidt J, Muller SK, Chatzitomaris A, Kurt M, Gerguri S, Clasen L, Klein HH, Kelm M, Makimoto H. Usefulness of Serum Free Thyroxine Concentration to Predict Ventricular Arrhythmia Risk in Euthyroid Patients With Structural Heart Disease. Am J Cardiol. 2020 Apr 15;125(8):1162-1169. doi: 10.1016/j.amjcard.2020.01.019. Epub 2020 Jan 29.

    PMID: 32087999BACKGROUND
  • Aweimer A, El-Battrawy I, Akin I, Borggrefe M, Mugge A, Patsalis PC, Urban A, Kummer M, Vasileva S, Stachon A, Hering S, Dietrich JW. Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study. J Intern Med. 2021 May;289(5):675-687. doi: 10.1111/joim.13189. Epub 2020 Nov 12.

    PMID: 33179374BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum aliquots are stored for postponed determination of non-classical thyroid hormones including but not limited to thyronamines, 3,5-diiodothyronine (3,5-T2) and reverse T3 (rT3).

MeSH Terms

Conditions

Heart ArrestVentricular FibrillationVentricular FlutterTachycardia, VentricularThyroid DiseasesCritical Illness

Interventions

Thyroid Function Tests

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesArrhythmias, CardiacPathologic ProcessesPathological Conditions, Signs and SymptomsTachycardiaCardiac Conduction System DiseaseEndocrine System DiseasesDisease Attributes

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, EndocrineDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Johannes W Dietrich, M.D.

    Bergmannsheil University Hospitals

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant endocrinologist

Study Record Dates

First Submitted

May 7, 2020

First Posted

May 18, 2020

Study Start

May 1, 2021

Primary Completion

June 1, 2022

Study Completion

December 31, 2022

Last Updated

August 19, 2021

Record last verified: 2021-08

Locations